Dr. Mohebtash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5601 Loch Raven Blvd
Baltimore, MD 21239Phone+1 443-444-3991- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
MedStar Health (Baltimore)Residency, Internal Medicine, 2003 - 2006
Tehran University of Medical Sciences School of MedicineClass of 1997
Certifications & Licensure
MD State Medical License 2006 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2014
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Start of enrollment: 2017 Jan 31
Publications & Presentations
PubMed
- Severe Thrombocytopenia in Infective Endocarditis.Mayuri Patel, Biplov Adhikari, Amrit Devkota, Mahsa Mohebtash> ;Journal of Community Hospital Internal Medicine Perspectives. 2023 Jan 1
- 3 citationsHALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving...Paula R Pohlmann, Deena Graham, Tianmin Wu, Yvonne Ottaviano, Mahsa Mohebtash, Shweta Kurian, Donna McNamara, Filipa Lynce, Robert Warren, Asma Dilawari, Suman Rao, Ca...> ;Breast Cancer Research and Treatment. 2022 Dec 1
- 7 citationsHematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.Filipa Lynce, Matthew Blackburn, Rebecca Zhuo, Christopher Gallagher, Olwen Hahn, Maysa M. Abu-Khalaf, Mahsa Mohebtash, Tianmin Wu, Paula R. Pohlmann, Asma Dilawari, S...> ;Cancer. 2021 Oct 1
- Join now to see all
Press Mentions
MedStar Health Cancer Program in Baltimore Earns Three-Year AccreditationMay 3rd, 2023
Professional Memberships
- Member
Hospital Affiliations
MedStar Union Memorial HospitalBaltimore, Maryland- MedStar Good Samaritan HospitalBaltimore, Maryland
- MedStar Harbor HospitalBrooklyn, Maryland
MedStar Franklin Square Medical CenterRosedale, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
